President and Co-Founder, Biovista
Aris Persidis is president and co-founder of Biovista. He also participated in the cofounding of Cellzome (GSK-acquired), Anadys (Roche-acquired), RheoGene (Inrtrexon-acquired), and was SVP at Upstate (Serologicals-acquired), and Serologicals (Millipore-acquired).
He wrote the Industry Trends column for Nature Biotechnology, was a judge for the 2011 Top-10 Innovations of The Scientist, is Editor-in-Chief of the journal Drug Repurposing, Rescue, and Repositioning, and has written about 100 papers, editorials, and book chapters. He was adjunct assistant professor at Wharton, and his PhD is in biochemistry, from Cambridge UK.